Cite
HARVARD Citation
Schaettler, M. et al. (2023). TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastoma. Journal for immunotherapy of cancer. 11 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Schaettler, M. et al. (2023). TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastoma. Journal for immunotherapy of cancer. 11 (2), p. . [Online].